StockNews.com Upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to “Buy”
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday. A number of other equities analysts have also weighed in on the stock. Citigroup boosted their price target on shares of Alnylam Pharmaceuticals […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday. A number of other equities analysts have also weighed in on the stock. Citigroup boosted their price target on shares of Alnylam Pharmaceuticals […]